Patents for C07D 209 - Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom (45,780) |
---|
06/04/2008 | CN100391944C Indoles useful in the treatment of androgen-receptor related diseases |
06/04/2008 | CN100391943C Preparation method of 3-position substituted indole derivative |
06/04/2008 | CN100391455C Use of isatin and oxindole derivatives in preparing medicine |
06/03/2008 | US7381842 For resist applications; thermostability, storage stability; color filters |
06/03/2008 | US7381739 Antiserotonine agents; central nervous system disorders; Alzheimer's disease; Parkinson's disease; Huntington's disease; sleep disorders |
06/03/2008 | US7381738 Substituted bicycloalkylamine derivatives as modulators of chemokine receptor activity |
06/03/2008 | US7381734 Serine protease inhibitors |
06/03/2008 | US7381730 Bone disorders, cardiovascular diseases, anticholesterol agents, hypertriglyceridemia, vasomotor disorders, urogenital disorders, prostatic hypertrophy, endometrial hyperplasia, anticarcinogenic agents; CNS disorders; side effect reduced |
06/03/2008 | US7381572 Using arsenic-mediated labeling to permit orthogonal molecule-specific, site-specific labeling of target molecules, such as proteins, with multiple labels; complex of peptide with tag of a cyanine dye having pendant 2,5-dithia-arsacyclopentane groups |
05/29/2008 | WO2008064320A2 Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity |
05/29/2008 | WO2008063673A1 Methods and compositions for controlling body weight and appetite |
05/29/2008 | WO2008063208A1 Method for purifying bisimides |
05/29/2008 | WO2008062636A1 Aromatic amine derivative and organic electroluminescent element using the same |
05/29/2008 | WO2008062167A2 Melatonin derivatives and their use as antioxidants |
05/29/2008 | WO2008061955A1 Benzoisoindole derivatives and their use as ep4 receptor agonists |
05/29/2008 | US20080125590 Anticancer agents |
05/29/2008 | US20080125589 Process for Production of Fluoro Derivative |
05/29/2008 | US20080125478 Substituted 2-indolinone as ptk inhibitors containing a zinc binding moiety |
05/29/2008 | US20080125476 Amorphous and crystalline forms; nonselective beta -adrenergic blocker with alpha 1-blocking activity; greater aqueous solubility and chemical stability |
05/29/2008 | US20080125472 Use of an inhibitor of the renin-angiotensin system; candesartan, candesartan cilexetil, losartan, valsartan, irbesartan, tasosartan, telmisartan, and eprosartan |
05/29/2008 | US20080125455 disorders of the central nervous system; cardiovascular disorders; gastrointestinal disorders; diabetes insipidus; sleep apnea; (S)-1-(2,3,7,8-tetrahydrofuro[2,3-g]indol-1-yl)-2-propylamine and (S)-1-[1-(1,2,3,6,7,8-hexahydrocyclopent[g]indolyl)]-2-propylamine |
05/29/2008 | US20080125430 New small molecule inhibitors of mdm2 and the uses thereof |
05/29/2008 | US20080125423 N-methyl-N-(1-methyl-1H-indol-3-ylmethyl)-3-(7-oxo-5,6,7,8-tetrahydro-1,8-naphthyridin-3-yl)acrylamide as an enzyme inhibitor for both Fab I and Fab K which are used in the biosynthesis of fatty acids; enoyl-acyl-carrier protein renamed Fab 1; bactericides; fungicides; Staphylococcus aureus; antibiotics |
05/29/2008 | US20080124577 Exhibits a light emission color with significantly high purity , highly efficient, highly luminant, and long-lived light emission; high glass transition temperature, heat stability and superior durability |
05/29/2008 | US20080124572 A carbazole skeleton to which a diarylamino group bonds via a bonding group as a hole transporting material or a hole injecting material has an enhanced efficiency of light emission and is highly practical; enhances yield in device, improves lifetime |
05/29/2008 | US20080124455 c6-c50 armoatic rings fused with pyrrole ring, substituted with diaminioaryliene rings; good solubility and high thermal stability; improved turn-on voltage, efficiency, color purity and luminance; wet spinning ( spin coating, spray or inkjet printing) and heat transfer |
05/29/2008 | US20080122344 Organic light emitting compound and organic light emitting device comprising the same, and method of manufacturing the organic light emitting device |
05/29/2008 | CA2670468A1 Melatonin derivatives and their use as antioxidants |
05/29/2008 | CA2670340A1 Tetrahydrocyclopenta[b]indole compounds as androgen receptor modulators |
05/29/2008 | CA2669104A1 Hydrindane analogs having sphingosine 1-phosphate receptor agonist activity |
05/28/2008 | EP1925303A2 Use of Angiotensin II type 1 receptor antagonists for the prevention of stroke, diabetes and/or congestive heart failure |
05/28/2008 | EP1924594A2 Novel macrocyclic inhibitors of hepatitis c virus replication |
05/28/2008 | EP1924557A2 Carbazole derivatives |
05/28/2008 | EP1924551A2 Organic compounds |
05/28/2008 | EP1768954A4 2-methylpropanamides and their use as pharmaceuticals |
05/28/2008 | EP1701940B1 2-(1h-indolylsulfanyl)-benzyl amine derivatives as ssri |
05/28/2008 | EP1556382B1 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof |
05/28/2008 | EP1546098B1 3,6-disubstituted azabicyclo [3.1.0]hexane derivatives useful as muscarinic receptor antagonists |
05/28/2008 | EP1399155B1 Small molecules useful in the treatment of inflammatory disease |
05/28/2008 | CN101189318A Reversibly thermochromic compositions |
05/28/2008 | CN101189243A Substituted heterocycles and their use as CHK1, PDK1 and PAK inhibitors |
05/28/2008 | CN101186593A Application of C60 triarylamine derivative in solar energy battery |
05/28/2008 | CN100390177C Preparation method of 6-cyano-7-methyl-1,1-(2,2-dimethyl-1,3-propylidine dioxy)-5-oxo-1,2,3,5-tetrahydro indolidin (I) |
05/28/2008 | CN100390165C Medicinal composition containing alkyl acyl ramosqiong and its application |
05/27/2008 | US7378440 Antidiabetic agents; therapy for insulin resistance |
05/27/2008 | US7378439 Process for the preparation of 4-(2-dipropylaminoethyl)-1,3-dihydro-2H-indol-2-one hydrochloride |
05/27/2008 | US7378438 Asthma; side effect reduction; converting SH groups to SNO groups of N-benzylphthalimide usingHCl and NaNO2; epoxide or thioepoxid of N-benzylphthalimide; amination; 5-{2-[(1-Yloxyl-2,2,5,5-tetramethyl-pyrrolidin-3-ylmethyl)-amino]-1-S-nitroso-ethyl}-1,1,3,3-tetramethylisoindolin-2-yloxyl, hydrochloride |
05/27/2008 | US7378437 Use for the diabetes treatment of compounds or salts thereof, having the following general formula (I): A-(B)b0-(C)c0-NO2 wherein A contains the radical of a drug having an antiiflammatory or analgesic activity, B is a bivalen: linking |
05/27/2008 | US7378431 Amide derivatives as NMDA receptor antagonists |
05/27/2008 | US7378412 Pharmaceutical compounds |
05/22/2008 | WO2008060998A1 Indole sulfonamides as sfrp-1 modulators |
05/22/2008 | WO2008060190A2 Ligands of 5-ht6 receptors, a pharmaceutical composition, method for the production and use thereof |
05/22/2008 | WO2008059943A1 Novel carbazole derivative and use thereof |
05/22/2008 | WO2008059713A1 Fluoranthene compound, organic electroluminescent device using the fluoranthene compound, and organic electroluminescent material-containing solution |
05/22/2008 | WO2008059521A2 Novel process for the preparation of moxifloxacin hydrochloride and a novel polymorph of moxifloxacin |
05/22/2008 | WO2008059335A1 Diaryl, dipyridinyl and aryl-pyridinyl derivatives and uses thereof |
05/22/2008 | WO2008059238A1 Benzenesulfonamide compounds as edg-1 antagonists useful in the treatment of cancer |
05/22/2008 | WO2008058402A1 Compounds and methods for treating protein folding disorders |
05/22/2008 | WO2007138431A3 Azabicyclic ether histamine-3 antagonists |
05/22/2008 | US20080119660 Method of making bisimides |
05/22/2008 | US20080119648 Histone deacetylase inhibitors |
05/22/2008 | US20080119520 Disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight; benzoxazole, benzimidazole, and indole compounds substituted with pyrrole, azepane, piperidine or azetidine e.g. 4-{2-[2-(2-methyl-pyrrolidin-1-yl)-ethyl]-benzooxazol-5-yl}-benzonitrile |
05/22/2008 | US20080119513 To treat osteoarthritis; matrix metalloproteinases-13 inhibitors |
05/22/2008 | US20080119490 Viral Polymerase Inhibitors |
05/22/2008 | US20080119485 Novel Benzofurans and Indols |
05/22/2008 | US20080119466 1-(4-Chloro-3-(trifluoro-methyl)phenyl)-3-(4-imidazo-[4,5-c]pyridin-1-ylphenyl)urea; Raf, a serine-threonine protein kinase inhibitor; Raf/MEK/ERK cascade in proliferation of human cancer cells; anticarcinogenic agent; psoriasis, atherosclerosis, chronic rheumatoid arthritis and diabetes |
05/22/2008 | US20080119442 as hypoxia-selective drugs and radiosensitizers for cancer therapy; nitroreductase inhibitor; 1-(Chloromethyl)-5,6-dinitro-3-(5,6,7-trimethoxyindol-2-carbonyl)-1,2-dihydro-3H-benzo[e]indole; halogenation of naphthalene derivative followed by hydration and cyclization |
05/22/2008 | CA2668744A1 Compounds and methods for treating protein folding disorders |
05/21/2008 | EP1923391A1 Substituted heterocyclic compounds, method for preparing same and pharmaceutical compositions containing them. |
05/21/2008 | EP1923387A1 Acylguanidine derivative or salt thereof |
05/21/2008 | EP1923386A2 Carbamate caspase inhibitors and uses thereof |
05/21/2008 | EP1923385A1 Iridium complex, carbazole derivatives and copolymer having the same |
05/21/2008 | EP1922359A1 A degradable polymer article |
05/21/2008 | EP1603558B1 Process for preparation of perindopril and salts thereof |
05/21/2008 | EP1482924B1 Cathepsin cysteine protease inhibitors |
05/21/2008 | EP1395551B1 Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases |
05/21/2008 | EP1362027B1 Acylated 6,7,8,9-tetrahydro-5h-benzocycloheptenyl amines and their use as pharmaceutical |
05/21/2008 | EP1261586B1 Cyclopropyl-fused pyrrolidine-based inhibitors of dipeptidyl peptidase iv, processes for their preparation, and their use |
05/21/2008 | CN101184759A Novel substituted tetracyclic tetrahydrofuran, pyrrolidine and tetrahydrothiophene derivatives and their use as a medicament |
05/21/2008 | CN101184732A Anthracene derivative, material for light-emitting element, light-emitting element, light-emitting device and electronic device |
05/21/2008 | CN101184731A New sulfonylindoline compounds |
05/21/2008 | CN101184730A New hybrid oligomers. their preparation process and pharmaceutical compositions containing them |
05/21/2008 | CN101184729A Inhibitors of cytosolic phospholipase a2 |
05/20/2008 | US7375237 Pyrrolizine compounds useful as anti-inflammatory agents |
05/20/2008 | US7375236 producing a morpholine-substituted phenacyl derivative, or a salt thereof, comprise reaction of a specific novel compound with morpholine, reaction of the product with a halogenating reagent, and deketalization of the product |
05/20/2008 | US7375134 N1-(1-cyanocyclopropyl)-4-fluoro-N2-{(1S)-2,2,2-trifluoro-1-[4'-(methylsulfonyl)-1,1'-biphenyl-4-yl]ethyl}-L-leucinamide; osteoporosis and other bone loss disorders |
05/20/2008 | US7375129 Bis-indole pyrroles useful as antimicrobials agents |
05/20/2008 | US7375127 Tetrahydrocarbazole derivatives having improved biological action and improved solubility as ligands of G-protein coupled receptors (GPCRs) |
05/20/2008 | US7375118 Phenyl-indole compounds for modulating IgE and Inhibiting cellular proliferation |
05/20/2008 | US7375116 NMDA (N-methyl-D-aspartate) receptors; eg 6-(4-benzylpiperidin-1-carbonyl)-1,5-dihydro-oxazolo[4,5-f]indole-2-one |
05/20/2008 | US7375099 Malonamide derivatives |
05/20/2008 | US7374857 Such as 5,5'-bis[2-nonafluorobutanesulfonyloxy-1H-isoindole-1,3(2H)-dione]; efficiency, solubility, stability, photosensitivity |
05/20/2008 | CA2395717C Fused imidazolium derivatives |
05/15/2008 | WO2008057775A2 Heterocyclic amide compounds useful as kinase inhibitors |
05/15/2008 | WO2008055994A1 Novel process |
05/15/2008 | WO2008055812A1 Spiroindolinone derivatives |
05/15/2008 | WO2008055808A1 Indole and benzofuran 2-carboxamide derivatives |
05/15/2008 | WO2008024492A3 Indolinone phenylaminopropanol derivatives and process for the preparation thereof |
05/15/2008 | US20080114179 Process and intermediates for the preparation of (1R,2S,5S)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates for salts thereof |
05/15/2008 | US20080114178 Containing n-[4-(9-carbazolyl)phenyl]-n-phenylamine in skeleton; stable light emission; long life; oxidation and reduction resistance |